Schonfeld Strategic Advisors’s Unity Biotechnology UBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-14,000
| Closed | -$38.4K | – | 2555 |
|
|
2022
Q4 | $38.4K | Buy |
+14,000
| New | +$38.4K | ﹤0.01% | 2235 |
|
|
2022
Q2 | – | Sell |
-3,870
| Closed | -$43K | – | 2892 |
|
|
2022
Q1 | $43K | Buy |
+3,870
| New | +$43K | ﹤0.01% | 2288 |
|
|
2021
Q4 | – | Sell |
-1,420
| Closed | -$43K | – | 2365 |
|
|
2021
Q3 | $43K | Sell |
1,420
-370
| -21% | -$11.2K | ﹤0.01% | 1921 |
|
|
2021
Q2 | $83K | Buy |
+1,790
| New | +$83K | ﹤0.01% | 1802 |
|
|
2020
Q4 | – | Sell |
-3,360
| Closed | -$116K | – | 1844 |
|
|
2020
Q3 | $116K | Buy |
+3,360
| New | +$116K | ﹤0.01% | 1219 |
|